We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+2.27%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.33B
AUM Growth
+$1.08B
Cap. Flow
+$1.18B
Cap. Flow %
16.06%
Top 10 Hldgs %
55.65%
Holding
321
New
63
Increased
80
Reduced
61
Closed
90

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$101M
2
ICLR icon
Icon
ICLR
+$97.6M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$87.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$82.5M
5
GSK icon
GSK
GSK
+$66.7M

Top Sells

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$40.5M
2
PTCT icon
PTC Therapeutics
PTCT
+$36.7M
3
SHAK icon
Shake Shack
SHAK
+$32.9M
4
INCY icon
Incyte
INCY
+$30.5M
5
CYTK icon
Cytokinetics
CYTK
+$30.4M

Sector Composition

Rank Sector Weight
1 Healthcare 39.34%
2 Consumer Discretionary 6.39%
3 Consumer Staples 5.37%
4 Technology 5.27%
5 Communication Services 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBUX icon
51
Starbucks
SBUX
$120B
$29.2M 0.4%
320,126
+132,027
+70% +$12.8M
CYTK icon
52
CALL
Cytokinetics
CYTK
$10.4B
$28.7M 0.39%
610,000
-1,590,000
-72% -$82.6M
NOMD icon
53
Nomad Foods
NOMD
$1.68B
$28.1M 0.38%
1,674,186
+1,333,273
+391% +$23.3M
TOST icon
54
Toast
TOST
$19.9B
$28M 0.38%
767,532
-252,703
-25% -$8.88M
DDOG icon
55
Datadog
DDOG
$84B
$27.4M 0.37%
191,787
-68,213
-26% -$9.37M
PFGC icon
56
Performance Food Group
PFGC
$18B
$27.1M 0.37%
320,144
+69,819
+28% +$5.89M
CENTA icon
57
Central Garden & Pet Co Class A
CENTA
$2.44B
$26.3M 0.36%
+795,761
New +$25.3M
ISRG icon
58
Intuitive Surgical
ISRG
$134B
$25.6M 0.35%
49,040
-8,286
-14% -$4.32M
SXT icon
59
Sensient Technologies
SXT
$5.53B
$24.9M 0.34%
350,000
+58,186
+20% +$4.48M
SHAK icon
60
Shake Shack
SHAK
$2.87B
$24.1M 0.33%
185,496
-268,478
-59% -$32.9M
THS
61
DELISTED
Treehouse Foods
THS
$23.7M 0.32%
675,440
+53,440
+9% +$1.95M
CHDN icon
62
Churchill Downs
CHDN
$6.12B
$23.4M 0.32%
175,591
+99,558
+131% +$13.8M
DYN icon
63
Dyne Therapeutics
DYN
$4.9B
$22.7M 0.31%
964,518
-190,686
-17% -$5.64M
WH icon
64
Wyndham Hotels & Resorts
WH
$5.48B
$22.6M 0.31%
224,629
+127,953
+132% +$11.9M
IRON icon
65
Disc Medicine
IRON
$2.97B
$22.6M 0.31%
356,000
+196,000
+123% +$11.3M
PLNT icon
66
Planet Fitness
PLNT
$3.78B
$22.2M 0.3%
224,946
-49,423
-18% -$4.51M
AUTL
67
Autolus Therapeutics
AUTL
$562M
$21.6M 0.3%
9,200,000
+2,328,000
+34% +$7.87M
STAA icon
68
STAAR Surgical
STAA
$1.21B
$21.2M 0.29%
872,000
+375,500
+76% +$10.7M
DPZ icon
69
Domino's
DPZ
$11.6B
$20.9M 0.29%
49,862
-51,314
-51% -$22.4M
XOM icon
70
ExxonMobil
XOM
$634B
$20.7M 0.28%
192,456
+14,093
+8% +$1.65M
MGNX icon
71
MacroGenics
MGNX
$257M
$20.4M 0.28%
6,276,000
+18,000
+0.3% +$64.8K
UBER icon
72
Uber
UBER
$153B
$20.2M 0.28%
335,535
+177,719
+113% +$12.7M
MKC icon
73
McCormick & Company Non-Voting
MKC
$14.2B
$20.1M 0.27%
+263,137
New +$20.7M
REGN icon
74
Regeneron Pharmaceuticals
REGN
$80.8B
$20M 0.27%
28,045
+8,013
+40% +$6.72M
TXRH icon
75
Texas Roadhouse
TXRH
$13.7B
$19.8M 0.27%
110,000
-15,076
-12% -$2.84M
1 2
3
4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Armistice Capital held 321 positions worth $7.33B, up 17% from $6.25B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital deployed $1.18B of net new capital in Q4 2024, opening 63 new positions and adding to 80 existing holdings. Its largest new stake was Exact Sciences: 1,617,000 shares worth $90.9M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was PTC Therapeutics, an estimated $36.7M trimmed.

  • Armistice Capital's largest Q4 2024 buy was Exact Sciences: 1,617,000 shares worth $90.9M.
  • Armistice Capital added most to Neurocrine Biosciences in Q4 2024, an estimated $87.9M increase.
  • Armistice Capital's biggest Q4 2024 reduction was PTC Therapeutics, cutting an estimated $36.7M.
  • Armistice Capital fully exited Alkermes in Q4 2024, selling an estimated $40.5M.
  • Armistice Capital's ten largest holdings make up 56% of its $7.33B portfolio in Q4 2024.
  • Armistice Capital opened 63 new positions and closed 90 in Q4 2024.
  • Armistice Capital's portfolio value rose 17% quarter-over-quarter to $7.33B.

Based on Armistice Capital's 13F filing for Q4 2024, filed 14 Feb 2025.